SCOUTT

SCOUTT

The Stepped Care for Opioid Use Train the Trainer (SCOUTT) operational initiative is working to implement a comprehensive plan to train interdisciplinary teams in Primary Care, General Mental Health, Pain Clinics and SUD Specialty Care clinics to deliver a stepped care model of medication treatment for opioid use disorder (M-OUD) to Veterans at his/her preferred care facility.

    Overview

    Overview of SCOUTT

    SCOUTT’s mission is to increase access to medication treatment for opioid use disorder (MOUD) in non-specialty care setting across the VA. Secondarily, SCOUTT is improving access to medication treatment for alcohol use disorder (MAUD), improving the quality of care for MOUD and MAUD across the VA, and enhancing the effectiveness of transitions of care between different providers and settings.

    train the trainer

    SCOUTT has recently expanded into Women’s Health, emergency rooms, and hospital settings. Further, there is extensive collaboration with operational partners and initiatives including pharmacy, pain, and primary care services. SCOUTT is also engaging in efforts to improve the quality of MOUD and MAUD in non-specialty care clinics and transitions of care between different settings of care.

    In part due to SCOUTT, over 50% of Veterans with opioid use disorder are on MOUD. As of 2024, more initiations of buprenorphine episodes of care occur outside of substance use disorder clinical settings. Furthermore, SCOUTT has been a clinical laboratory where several VA investigators are funded for Investigator-Initiated Research and Career Development Awards.

    Background:

    SCOUTT was designed with the intent of improving Veteran access to M-OUD treatment outside the confines of specialty addiction care and to capitalize on the Stepped Care for Opioid Use Train the Trainer (SCOUTT) operational initiative. After two national webinars during the Spring of 2018, SCOUTT was formally kicked off with a large national conference attended by nearly 300 VA staff from 18 VISNs, VACO leadership, and key stakeholders in August of 2018. At the two-day conference attended by facility non-specialty care implementation teams including 4 VISN leaders from each VISN, SCOUTT Facility Implementation Teams (SCOUTT FITs) were educated on two models to integrate SCOUTT into VA facilities, a medication management model and a case management model.

    Teams developed action steps to integrate SCOUTT process in two clinic environments during the first-year post-conference (Phase 1). In the subsequent year, SCOUTT expanded to 18 other facilities (Phase 2). Then, beginning in 2022, SCOUTT expanded to over 50 facilities, offering education and support to various primary care, mental health, and pain clinics on an ad hoc basis (Phase 3). Finally, in 2024, the SCOUTT initiative began offering its interventions and services to all VA facilities across the nation (Phase 4).

    scoutt 2

    SCOUTT facilitators have engaged 18 SCOUTT Facility Implementation Teams (SCOUTT FITs) with monthly implementation meetings (at least 1 hour each) and additional mentorship and leadership calls as needed. Facilitators meet at least 1 hour weekly to compare notes and inform VACO leadership of the implementation progress. In addition, the PEC-19-001 meet at least 1 hour monthly with an ongoing planning committee meeting of national VA stakeholders regarding the progress of the initiative.

    To date, SCOUTT leadership has conducted 40 tailored site visits and presentations with individual facilities, interest groups, and providers. In 2019, SCOUTT leadership conducted 2-day site visits at Lake City, Florida and Hampton, Virginia. During these visits, a buprenorphine waiver training was conducted where over 60 staff were trained on the provision of medication treatment for opioid use disorder for Veterans. In addition, in site visits the facilitators also visited with VISN leadership, Mental Health, Primary Care, Pain Clinic, Pharmacy, social work and/or conducted several training sessions with SCOUTT implementation team. The team reviewed how patients are selected for treatment, what induction day looks like at their clinic, and toured the facilities. Site reports were provided to the sites. At three sites, facility leadership was briefed regarding SCOUTT in a dedicated session, and VA facility leadership interacted with the PEC-19-001 team ad hoc at nearly all site visits.

    funding

    Facilitation of the Stepped Care Model and Medication Treatment for Opioid Use Disorder is a Partnered Evaluation Initiative funded by the Quality Enhancement Research Initiative (QUERI) from the Department of Veterans Affairs.

    Since 2018, SCOUTT has hosted bimonthly education meetings to help support sites expanding SUD care at their facilities. Pilot facilitation calls were used to share announcements and allow SCOUTT sites an opportunity to share successes and challenges they’ve faced while being able to collaborate with other sites and leadership. As of December 2024, this call has been hosted 66 times totaling nearly 5,600 attendees. In November 2024 these calls were changed to the “SCOUTT Action Hour” and focused on presentations and discussions from clinicians sharing practical clinical advice in a variety of SUD-related areas. SCOUTT also hosts its ILEAD-supported webinar series which began in October 2018. As of December 2024, this national accredited series has been hosted 67 times with an average attendance of 123 for each webinar. This series has been fortunate to have a diverse group of researchers and clinicians sharing their expertise and research with our audience.

    SCOUTT AIMS:

    AIM 1

    This program focusses on implementing a comprehensive plan to train interdisciplinary teams in Primary Care, General Mental Health, Pain Clinics and SUD Specialty Care clinics to deliver a stepped care model of medication treatment for OUD in order to provide treatment services around the Veteran at his/her preferred point of care.
    AIM 2

    Develop, implement, deliver, produce and sustain SCOUTT strategies and products across all VISNs.
    AIM 3

    Facilitate, train, and mentor VISN-wide SCOUTT Pilot Team members through face-to-face meetings and community of practice webinars.

    SCOUTT ACCOMPLISHMENTS:

    • Held 3 national conferences with hundreds of attendees where teams were trained on models of medication treatment for opioid use disorder (MOUD) care.
    • Conducted 28 site visits across 16 VISNs to train teams implementing the train-the-trainer models and educate on MOUD.
    • Held routine calls with facilitators to identify barriers and brainstorm ideas to eliminate the barriers.
    • Held over 50 webinars where SCOUTT teams provided updates on activities and progress made in MOUD expansion.
    • Beginning in November 2024, successful transition to hosting the SCOUTT Action Hour: Elevating SUD Care Together. This is a monthly series designed to enhance provider knowledge/awareness of SUD treatments within the VA.
    • Hosting over 70 meetings with ILEAD (formerly EEs) to provide regular accredited webinars focused on the impact of SUDs on Veterans.
    • Authored over 20 peer-reviewed papers across multiple journals.
    • From 2020 through 2023, SCOUTT facilitated 12 buprenorphine x-waiver trainings with over 900 attendees.
    • Management of multiple listservs and responding to questions posted on the same listservs.
    • Identified and invited leaders in the field to present on topics related to SCOUTT and substance use disorders.
    • Has conducted surveys and interviews with providers, evaluating the responses in order to improve understanding of clinician perspectives.
    • Collaborated with VACO leadership on VHA Notice 2019-18 buprenorphine prescribing for opioid use disorder and on an Emergency Department Opioid Initiative.
    • Completed pre-implementation activities including asking VISN leaders to nominate a SCOUTT team at each VISN comprised of a pain specialist lead, a primary care lead and two clinical champions.

    SCOUTT TEAM & SPONSOR:

    Principal Investigator: Adam Gordon, MD, MPH, FACP, DFASAM
    Facilitators: Hildi Hagedorn, PhD
    Marie Kenny, BS
    Amanda Midboe, PhD
    Princess Ackland, PhD LP, MSPH
    Implementation Scientist: Eric Hawkins, PhD
    Sponsor: Quality Enhancement Research Initiative (QUERI); Department of Veterans Affairs; PEC-19-001

    HAVE QUESTIONS?

    Contact us here:

    Spencer Calder, MPH - Academic Program Manager

    spencer.calder@va.gov or spencer.calder@hsc.utah.edu

    Andrea Stofko - Research Analyst

    andrea.stofko@va.gov or andrea.stofko@utah.edu

     

    Updates

    SCOUTT Milestones and Updates

    April 2025

    On April 21st, 2025, the Women’s Health SCOUTT initiative hosted a half-day virtual conference entitled Substance Use Disorders and Women’s Health: Collaboration and Training in partnership with the Office of Mental Health. This accredited educational program was designed to train physicians, nurses, pharmacists, and mental health clinicians on evidence-based methods to improve care for women Veterans with substance use disorders. Over 400 VA clinicians and staff attended the conference.

    December 2024

    As we enter Phase 4 of SCOUTT, we have shifted towards an open, all-encompassing approach to the SCOUTT initiative. Rather than electing certain designated facilities to receive SCOUTT education and support, we now offer SCOUTT services in all VA facilities across the nation, regardless of their MOUD or MAUD performance.

    November 2024

    This month marked the commencement of a new monthly SCOUTT educational series entitled, “SCOUTT Action Hour: Elevating VA SUD Care Together.” Rooted in collaboration and shared learning, SCOUTT Action Hour fosters a supportive community where VA providers uplift one another, share challenges and successes, and work together to enhance substance use disorder care for Veterans.

    To receive a meeting invite, please contact spencer.calder@va.gov or adam.gordon@va.gov.

    HAVE QUESTIONS?

    Contact us here:

    Spencer Calder, MPH - Academic Program Manager

    spencer.calder@va.gov or spencer.calder@hsc.utah.edu

    Andrea Stofko - Research Analyst

    andrea.stofko@va.gov or andrea.stofko@utah.edu

     

    Education

    SCOUTT Action Hour

    “SCOUTT Action Hour: Elevating VA SUD Care Together” is a monthly series designed to enhance provider knowledge and awareness of substance use disorder treatments within the VA. Each session features expert speakers and providers sharing their experiences and insights on expanding access to and improving care for Veterans with substance use disorders. While formats may vary, sessions follow a fireside-style approach, combining presentations with open discussion, questions, and collaboration.

    Rooted in collaboration and shared learning, SCOUTT Action Hour fosters a supportive community where VA providers uplift one another, share challenges and successes, and work together to enhance substance use disorder care for Veterans. These interactive sessions take place on the 1st Wednesday of each month at 12pm ET via Microsoft Teams. All are welcome to attend. To receive a meeting invite, please contact spencer.calder@va.gov or adam.gordon@va.gov.

    SCOUTT ILEAD Series

    These are accredited, didactic calls supported by the Institute for Learning, Education and Development (ILEAD) in which clinicians and researchers share their work on caring for Veterans with substance use disorders. These presentations primarily focus on OUD, but are expanding into alcohol use disorder, cannabis use disorder, and care for women Veterans. These calls are recorded. They occur on Adobe Connect on the 2nd Wednesday of each month at 1pm ET. Although presentations are primarily targeted towards VA providers and personnel, all are welcome to attend.

    Upcoming Presentations

    "Improving Treatment for Unhealthy Alcohol Use." Presented by Rachel Bachrach, PhD on July 9, 2025 at 1pm ET. Please reach out to spencer.calder@va.gov or andrea.stofko@va.gov if you would like more information.

    Past Presentations

    Please email spencer.calder@va.gov if you would like the link to any of the below presentations. These calls are primarily focused on Veterans.

    2025

    • "VA Emergency Medicine Addiction Hotline (VEMAH): Bridging the Emergency Department and SUD Worlds" – Cynthia Koh, Manuel Celedon
    • "Acute Pain Management When Prescribed Buprenorphine" – Thomas Hickey
    • "Clinical Pharmacist Practitioners Prescribing of Buprenorphine for Opioid Use Disorder" – Adam Gordon
    • "Methadone for OUD for the Generalist: Everything You Wanted to Know but Were Afraid to Ask" – David Lawrence, Katie Jones
    • "Utilizing High-Dose Buprenorphine to Safely Treat Opioid Use Disorder" – Adam Gordon
    • "Taking Long-Acting Buprenorphine to the STIX" – Eric Gibbs, Courtenay Wilson, Emmeline Bone, Meghan Duquette
    • "Social Connection and Purpose in Life: Remedy for US Veterans with Substance Use Disorder" – Peter Na
    • "Developing and Maintaining a Syringe Service Program in the VA" – Natalie Valentino, Jessica Steadman, Catherine Yao
    • "Improving Care Transitions After Medical Hospitalization for People with Substance Use Disorders" – Mike Incze

    2024

    • "Perspectives of Homeless Veterans Living with Substance Use Disorders and Mental Illness" - Christian Betancourt
    • "Injectable Buprenorphine: An Overview of Implementation and Education at a VA Site" - Natalie Valentino, Jessica Steadman
    • "Revising Current Assumptions to Effectively Manage Long-Term Opioid Therapy and Its Deprescribing" - Ajay Manhapra
    • "Batter Up: How Pharmacists Have Stepped Up to the Plate to Increase Buprenorphine Access for OUD" - Eric Gibbs, Haley Pals
    • "Are Rates of Retention on Buprenorphine Improving Equitably Among Veterans?" - Corey Hayes, Rebecca Raciborski, Clare Brown, Adam Gordon, Teresa Hudson, Bradley Martin, George Pro, Michael Cucciare
    • "OUD is All We Need" - Karen Drexler
    • "'I'm Clean and Sober, But Not Necessarily Free': Perceptions of Buprenorphine Among Patients in Long-Term Treatment" - Jessica Wyse
    • "HIV Prevalence and HIV Screening History Among a Veterans Association Cohort of People with Opioid and Alcohol Use Disorders" - Nicole McCann, Amar Mandavia, Michael Davenport, Michael Stein, Nicholas Livingston
    • "Systematically Testing the Evidence on Marijuana" - Devan Kansagara
    • "Impact of a VHA Mandated Case Review Policy on Opioid Discontinuation and Mortality Among Long-Term Opioid Therapy Patients" - Yufei Li
    • "The Radical Drug Policy We Need: Regulating Alcohol" - Keith Humphreys

    2023

    • "Improving Treatment for Unhealthy Alcohol Use" 
    • "Gender Informed Care for Women Veterans Who Use Substances" - Sara Spinella
    • "Developing a Primary-Care Based Buprenorphine Clinic and E-Consult: lessons from implementation science" - Jessica Wyse Katherine Mackey
    • "Addressing Homelessness, Serious Mental Illness, and Substance Use Disorders among Veterans" - Sonya Gabrielian Matthew McCoy
    • "Multi-level barriers and facilitators to treatment for alcohol use disorder" - Tessa Matson, Jessica Chen, Madeline Frost
    • "Buprenorphine 2023" - Thomas Hickey
    • "The Women's Recovery Group Curriculum Adapted for Veterans: An Overview" - Tracy Simpson, Rebekah Barton
    • "Qualitative Analysis of Patient Perspectives of Buprenorphine After Transitioning from Long-Term, Full Agonist Opioid Therapy Among Veterans with Chronic Pain" - Sara Edmond, Danielle Wesolowicz
    • "Nature vs Nurture? Positive psychosocial factors buffer genetic risk for substance use disorders and suicidal thoughts" - Peter Na
    • "Introduction to the “new” Extended-Release Buprenorphine Product (Cam2028 or “Brixadi”) for the treatment of opioid use disorder" - Adam Gordon, Margaret Rupprecht

    2022

    • "MOUD-ED and/or Bridge Clinics" - Comilla Sasson
    • "Advancing Access to Pharmacological Treatment for Opioid Use Disorder: Results of the ADaPT-OUD Implementation Trial" - Allison Gustavson, Adam Gordon
    • "Systematically Testing the Evidence on Marijuana" - Devan Kansagara, Curtis Harrod
    • "Meeting the Veteran in Primary Care: Leveraging the clinical Pharmacist Practitioner to Improve Access" - Veldana Aliu
    • "Two Years of 'Ask the expert -- Substance Use Disorders': FAQs" - Ellen Edens
    • "Provider Incentives to Prescribe Buprenorphine for Opioid Use Disorder in Primary Care: A Preference Analysis." - Jordynn Wilcox
    • "Beyond state scope of practice laws for advanced practitioners – Additional supervision requirements for buprenorphine prescribing" - Basia Andraka-Cristou
    • "Influences of Physical Activity on Addiction and Addiction Treatment: Evidence, Methods, Mechanisms, and Future Directions" - Adam Gordon
    • "SCOUTT through Four Years: What We Planned, What We Accomplished, and Where We are Going" - Adam Gordon, Hildi Hagedorn, Eric Hawkins
    • "Pharmacotherapy for Alcohol Use Disorder" - Kyle Kampman
    • "Telehealth MOUD care to a CBOC: Collaborative base care model" - Alyssa Braxton

    2021

    • "Clinical Pharmacy Specialist Provider Impact on MOUD in Primary Care" - Tera Moore
    • "Establishing Different Models of Level 1 Care in the SCOUTT Initiative – What is Necessary and Sufficient?" - Adam Gordon
    • "Using the Buprenorphine Patient Report to Improve Patient Care" - Chad Kay
    • "Buprenorphine Initiation: how to do it seamlessly and effectively in various settings" - Adam Gordon
    • "Contingency Management and the Role of Rapid UDS in supporting it" - Dominick DePhilippis
    • "Implementation of a pharmacist care model for MOUD." - Beth DeRonne, Erin Krebs
    • "Evaluating Quality of Care for Opioid Use Disorder" - Taylor Kelley
    • "Buprenorphine 101 for the non-Addictionologist" - Adam Gordon
    • "The sustainability and impact of COVID-19 on MOUD delivery during the Stepped Care for Opioid Use Disorder Train-the-Trainer (SCOUTT) initiative." - Eric Hawkins
    • "A Review of Low-Dose Buprenorphine Initiation (aka “Microdosing”) – How to Accomplish in VA Settings" - Adam Gordon

    2020

    • "The emerging role of buprenorphine in opioid dependence and pain" - William Becker
    • "QUERI VISN 22 Pilot to Increase Access to MAT and CIH in Primary Care" - Evelyn Chang and Rebecca Oberman
    • "Tele-health Approaches to Prescribing MAT" - David Moore and Marc Rosen 
    • "Buprenorphine formulation for chronic pain management in patients with OUD or long-term opioid therapy with Physiological tolerance” - Adam Gordon
    • "Buprenorphine formulation for chronic pain management in patients with OUD or long-term opioid therapy with Physiological tolerance”. - Hilary Mosher
    • "Implementation of Medication Treatment in Rural and CBOC Settings: Progress and Opportunities." - Adam Gordon and Matthew Dungan
    • "Introduction and Updates on SCOUTT" - Adam Gordon and Jennifer Burden
    • "SCOUTT Facilitation, Implementation and Evaluation" - Hildi Hagedorn and Eric Hawkins
    • "Addressing the Relations between Opioid Use Disorder, Suicide Risk, and Overdose" - Elizabeth Oliva
    • "The Opioid Taper: The Clinical Case for Humility in Medical Decision-Making" - Stefan Kertesz
    • "Buprenorphine for OUD, Buprenorphine for Pain, and OEND Guidance Updates" - Mitch Nazario

    2019

    • "Office Based Treatment of Buprenorphine: What is Necessary and Sufficient to Prescribe in VA Office" - Adam Gordon
    • "Introduction to Injectable Buprenorphine" - Adam Gordon
    • "Buprenorphine Dashboards: How to Use Data to Optimize Patient Care" - Michael A. Harvey, Pharm.D., BCPS
    • "So what are these VISN Partnered Implementation Initiatives?" - Adam Gordon
    • "Mini-Residency: Experiences and lessons learned" - Ellen Edens and team
    • "America’s Opioid Epidemic: Treating Opioid Addiction in Primary Care" - Ilene Robeck and Stephen Mudra
    • "Why should WE take care of YOUR patients?” - What Bedford VA has learned - Dongchan Park, M.D.
    • "Recommendations for Use: Buprenorphine Formulations for Chronic Pain Management in Patients with OUD or on Long Term Opioid Therapy with Physiologic Tolerance and Dependence." - Mitchell Nazario
    • "The Definition Of Addiction To Opioids And How To Code For It" - Adam Gordon, Karen Drexler, Ilene Robeck
    • "The Collaborative Care Model applied to Medication Assisted Treatment for SUD" - Andrew Pomerantz
    • "Initiative to improve drug screening in Primary Care to inform treatment." - Michael Saenger and Dominic DePhillip
    • "SCOUTT at a Year: Lessons Learned, Achievements, and Opportunities Going Forward" - Adam Gordon, Eric Hawkins, Karen Drexler, Jennifer Burden, Hildi Hagedorn

    2018

    • "Treatment of Prescription Opioid Dependence and the Role of Counseling with Buprenorphine TX" - Dr. Weiss
    • "Multidisciplinary Management of Chronic Pain" - Dana Cervone, Sara Edmond, Ellen Edens
    • "Introduction to the uses of long-acting injectable naltrexone (XR-NTX)" - Maria Sullivan

    HAVE QUESTIONS?

    Contact us here:

    Spencer Calder, MPH - Academic Program Manager

    spencer.calder@va.gov or spencer.calder@hsc.utah.edu

    Andrea Stofko - Research Analyst

    andrea.stofko@va.gov or andrea.stofko@utah.edu

     

    Women's Health

    SCOUTT Comprehensive Women's Health

     

    The VA has been asked to improve access to evidence based treatment for substance use disorders (SUD) to women Veterans. The mission of the SCOUTT- Comprehensive Women’s Health (SCOUTT-CWH) Expansion Initiative is to improve SUD treatment for women Veterans throughout the Veterans Health Administration. Beginning in October 2022 (FY 2023), the intention of this program was to engage clinical teams from the Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative with four Comprehensive Women’s Health Programs to help facilitate care (Phase 1). The program is currently working to expand SUD treatment in Minneapolis, Portland, Puget Sound, and Salt Lake City. Over time, the SCOUTT-CWH Expansion Initiative will expand to other sites (Phase 2).

    scoutt-cwhp
    scoutt-cwhp sites

    Women’s Health SUD Conference

    About

    In April of 2025, the Women’s Health SCOUTT initiative hosted a virtual conference entitled Substance Use Disorders and Women’s Health: Collaboration and Training in partnership with the Office of Mental Health. This accredited training program for VA physicians, nurses, pharmacists, and mental health providers aimed to enhance awareness of SUD treatment in women's health care settings. Many providers lack confidence in identifying and treating SUDs in women Veterans, particularly during the peri-natal and postpartum periods. Both the gap in knowledge among clinicians and the growing population of female Veterans underscore the critical need for targeted education for health care providers responsible for their care.

    A total of 432 VA clinicians and staff attended the half-day educational conference hosted by the Women’s Health SCOUTT initiative on April 21st, 2025.

    To address these knowledge gaps, this conference provided guidance and practical solutions that can be implemented to support alcohol use disorder (AUD) and opioid use disorder (OUD) treatment for women Veterans in women's health care and primary care settings. These presentations aimed to increase knowledge about the identification, assessment, and treatment of substance use disorders in women Veterans, and increase access to this care outside of SUD specialty clinics. Clinicians were informed on how to better utilize available VA services and implement evidence-based substance use treatment across the VA continuum of care.

    Objectives

    This conference was designed to prepare clinicians to:

    • Describe at least two SUD problems facing women Veterans;
    • Identify SUDs in women Veterans’ health care settings through assessment and screening;
    • Discuss medication treatment for alcohol use disorder and opioid use disorder among women Veterans in women Veteran health care settings; and
    • Evaluate at least two key considerations for supporting medicated opioid use disorder and SUD treatment for Women Veterans with children at home

    HAVE QUESTIONS?

    Contact us here:

    Andrea Stofko

    andrea.stofko@va.gov 

    or andrea.stofko@utah.edu

    SALIENT

    SCOUTT Evaluation Through SALIENT

    The SCOUTT Evaluation through the StrAtegic PoLicy EvIdence-Based Evaluation CeNTer (SALIENT) is an ongoing quantitative evaluation of a variety of outcomes of the SCOUTT initiative. Conducted in partnership with the Office of Connected Care, the SCOUTT SALIENT evaluation aims to examine patient access to buprenorphine medication for opioid use disorder (B-MOUD) and compare patient outcomes of retention and mortality between intervention and non-intervention sites by examining electronic health records of individuals accessing B-MOUD care through the VHA. We are using prescription level evaluations to identify trends in access by outpatient healthcare setting. We are using patient level evaluations to identify differences in patient outcomes by the location of B-MOUD initiations of treatment.

    SALIENT QUERI Logo

    Implications

    Restricting access to B-MOUD care through addiction specialized environments is a barrier that may be reduced if B-MOUD is made more available through more commonly utilized healthcare connection points like primary care, mental health, and pain clinics. We present evidence that this expanding care is occurring across the VHA. Furthermore, we demonstrate the success of SCOUTT training, providing quantitative evidence that the clinician level intervention was able to change the landscape of addiction care at a facility level. We provide evidence that patients do not experience poorer outcomes from initiating care in non-addiction-specialty settings, lending support to the recent VHA and national policy changes shifting away from the restriction of B-MOUD care.

    Milestones

    • Six papers are in development; one paper is under review at the Journal of the American Medical Association.
    • In June 2025, we will discuss the results of our evaluation on a symposium titled "Policies to Expand Access to Medications for Opioid Use Disorder: The VA Experience" at the Academy Health Annual Research Meeting.

    Future Products

    • "Buprenorphine Treatment for Opioid Use Disorder in Non-Addiction-Specialty Settings in the Veterans Administration:" A brief report that describes the trend in the outpatient prescription setting of B-MOUD shifting from overwhelmingly addiction-specialty settings to nearly half non-addiction-specialty setting. 

    • "Mortality Outcomes Do Not Differ By Setting of Buprenorphine Initiation Among Veterans with Opioid Use Disorder:" An original research manuscript that describes the differences in patient outcomes, and lack thereof, between patient who initiate B-MOUD in specialty-addiction settings versus non-specialty-addiction settings.

    Funding

    This evaluation is funded by the Quality Enhancement Research Initiative (QUERI).

    HAVE QUESTIONS?

    Contact us here:

    Spencer Calder, MPH - Academic Program Manager

    spencer.calder@va.gov or spencer.calder@hsc.utah.edu

    Sophie Huebler, MS - Biostatistician

    sophia.huebler@va.gov or sophie.huebler@utah.edu

    Research

    Recent Publications

    Bolded papers indicate facility SCOUTT clinic descriptions:

    1. Percy A, Kelley AT, Valentino N, Butz A, Baylis JD, Suo Y, Gordon AJ, Jones AL. Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders. Subst Abus. 2023 Oct 15:8897077231198679. doi: 10.1177/08897077231198679. Epub ahead of print. PMID: 37840212. 
    2. Gordon AJ, Drexler K, Hawkins EJ, Burden J, Codell NK, Mhatre-Owens A, Dungan MT, Hagedorn H. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Subst Abus. 2020;41(3):275-282. doi: 10.1080/08897077.2020.1787299. PMID: 32697170; PMCID: PMC7849630.
    3. DeRonne BM, Wong KR, Schultz E, Jones E, Krebs EE. Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder. Am J Health Syst Pharm. 2021 Feb 8;78(4):354-359. doi: 10.1093/ajhp/zxaa405. PMID: 33326564.
    4. Lei J, Butz A, Valentino N. Management of kratom dependence with buprenorphine/naloxone in a veteran population. Subst Abus. 2021;42(4):497-502. doi: 10.1080/08897077.2021.1878086. Epub 2021 Feb 22. PMID: 33617752.
    5. Codell N, Kelley AT, Jones AL, Dungan MT, Valentino N, Holtey AI, Knight TJ, Butz A, Gallop C, Erickson S, Patton J, Hyte-Richins LJ, Rollins BZ, Gordon AJ. Aims, development, and early results of an interdisciplinary primary care initiative to address patient vulnerabilities. Am J Drug Alcohol Abuse. 2021 Mar 4;47(2):160-169. doi: 10.1080/00952990.2020.1832507. Epub 2020 Dec 10. PMID: 33301347; PMCID: PMC8062280.
    6. Hawkins EJ, Danner AN, Malte CA, Blanchard BE, Williams EC, Hagedorn HJ, Gordon AJ, Drexler K, Burden JL, Knoeppel J, Lott A, Sayre GG, Midboe AM, Saxon AJ. Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities. Addict Sci Clin Pract. 2021 Sep 6;16(1):55. doi: 10.1186/s13722-021-00263-5. PMID: 34488892; PMCID: PMC8419813.
    7. Kelley AT, Dungan MT, Gordon AJ. Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19. J Addict Med. 2021 Sep-Oct 01;15(5):439-440. doi: 10.1097/ADM.0000000000000786. PMID: 33323694; PMCID: PMC8489586.
    8. Spelman JF, Edens EL, Maya S, Moore BA, Boggs A, MacLean RR, Ackland P, Becker WC, Lynch D, Garcia-Vassallo M, Burgo AL, Rosen MI, Gordon AJ. A Facility-Wide Plan to Increase Access to Medication for Opioid Use Disorder in Primary Care and General Mental Health Settings. Fed Pract. 2021 Oct;38(10):460-464. doi: 10.12788/fp.0186. PMID: 34733066; PMCID: PMC8560103.
    9. Hawkins EJ, Malte CA, Gordon AJ, Williams EC, Hagedorn HJ, Drexler K, Blanchard BE, Burden JL, Knoeppel J, Danner AN, Lott A, Liberto JG, Saxon AJ. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System. JAMA Netw Open. 2021 Dec 1;4(12):e2137238. doi: 10.1001/jamanetworkopen.2021.37238. PMID: 34870679; PMCID: PMC8649831.
    10. Gordon AJ, Kenny M, Dungan M, Gustavson AM, Kelley AT, Jones AL, Hawkins E, Frank JW, Danner A, Liberto J, Hagedorn H. Are x-waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x-waiver trainings. Am J Addict. 2022 Mar;31(2):152-158. doi: 10.1111/ajad.13260. Epub 2022 Feb 3. PMID: 35118756.
    11. Jones AL, Kelley AT, Suo Y, Baylis JD, Codell NK, West NA, Gordon AJ. Trends in Health Service Utilization After Enrollment in an Interdisciplinary Primary Care Clinic for Veterans with Addiction, Social Determinants of Health, or Other Vulnerabilities. J Gen Intern Med. 2022 Feb 22:1–9. doi: 10.1007/s11606-022-07456-x. Epub ahead of print. PMID: 35194740; PMCID: PMC8862702.
    12. Radmall AO, Calder S, Codell N, Kelley AT, Hawkins E, Jones AL, Hagedorn H, Reynolds MA, Gordon AJ. Roles and perceptions of nurses during implementation of a medication treatment for opioid use disorder national initiative. J Addict Nurs. 2022;33(2):70-79. PMID: 3564010
    13. Wyse JJ, Mackeu K, Lovejoy TI, Kansagara D, Tuepker A, Gordon AJ, Korthuis TP, Herreid-O’Neill A, Williams B, Morasco BJ. Expanding access to medications for opioid use disorder through locally initiated implementation. Addict Sci Clin Pract. 2022;17(1):32. PMID: 35725648
    14. Kelley AT, Wilcox J, Baylis JD, Crossnohere NL, Magel J, Jones AL, Gordon AJ, Bridges JFP. Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives. J Gen Intern Med. 2022 Dec 5. doi: 10.1007/s11606-022-07975-7. Epub ahead of print. PMID: 36471194
    15. Lott AM, Danner AN, Malte CA, Williams EC, Gordon AJ, Halvorson MA, Saxon AJ, Hagedorn HJ, Sayre GG, Hawkins EJ. Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation. J Addict Med. 2023 Mar 2. doi: 10.1097/ADM.0000000000001156. Epub ahead of print. PMID: 36862502

     

     

     

    HAVE QUESTIONS?

    Contact us here:

    Spencer Calder, MPH

    spencer.calder@va.gov 

    or spencer.calder@hsc.utah.edu

    Annual Reports

    Read our Annual Reports here:

    2024 Annual Report
    2023 Annual Report